Bill Chang

Associate Professor

  • 2200 Citations
  • 24 h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Bill Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    • 2200 Citations
    • 24 h-Index
    • 42 Article
    • 2 Letter
    • 1 Short survey

    Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

    Eide, C. A., Kurtz, S. E., Kaempf, A., Long, N., Agarwal, A., Tognon, C. E., Mori, M., Druker, B. J., Chang, B. H., Danilov, A. V. & Tyner, J. W., Jan 1 2020, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalArticle

  • Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche

    Abdelhamed, S., Butler, J. T., Doron, B., Halse, A., Nemecek, E., Wilmarth, P., Marks, D., Chang, B., Horton, T. & Kurre, P., Jul 1 2019, In : EMBO Reports. 20, 7, e47546.

    Research output: Contribution to journalArticle

  • Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure

    Lucero, O. M., Parker, K., Funk, T., Dunlap, J., Press, R., Gardner, R. A. & Chang, B. H., Jul 2019, In : British Journal of Haematology. 186, 2, p. 333-336 4 p.

    Research output: Contribution to journalLetter

    Open Access
    3 Scopus citations

    Replication timing alterations in leukemia affect clinically relevant chromosome domains

    Rivera-Mulia, J. C., Sasaki, T., Trevilla-Garcia, C., Nakamichi, N., Knapp, D. J. H. F., Hammond, C. A., Chang, B. H., Tyner, J. W., Devidas, M., Zimmerman, J., Klein, K. N., Somasundaram, V., Druker, B. J., Gruber, T. A., Koren, A., Eaves, C. J. & Gilbert, D. M., Nov 12 2019, In : Blood Advances. 3, 21, p. 3201-3213 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells

    Nechiporuk, T., Kurtz, S. E., Nikolova, O., Liu, T., Jones, C. L., D’alessandro, A., Culp-Hill, R., D’almeida, A., Joshi, S. K., Rosenberg, M., Tognon, C. E., Danilov, A. V., Druker, B. J., Chang, B. H., McWeeney, S. K. & Tyner, J. W., Jul 2019, In : Cancer discovery. 9, 7, p. 910-925 16 p.

    Research output: Contribution to journalArticle

  • 14 Scopus citations